Filing Flows › Agenus (AGEN) › Recalls, complaints & regulation
Agenus (AGEN): clinical trials
Agenus (AGEN) beyond its filings: 2 active clinical trials.
Agenus' latest quarter
Agenus, Q3 2026: revenue $31.5M (+4% year over year), operating margin 36.2%, net earnings $1.5M, operating cash flow −$20.1M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Agenus have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.